uniQure N.V. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of uniQure N.V. (QURE)
NEW YORK CITY, NY / ACCESS Newswire / September 30, 2026 /Levi & Korsinsky notifies investors that it has commenced an investigation into uniQure N.V. ("uniQure N.V.") (NASDAQ:QURE) concerning potential violations of the federal securities laws.
Shares of uniQure N.V. opened down nearly 40% on September 29, 2026, following the release of mixed 48-month clinical data for AMT-130, its gene therapy for Huntington 's disease. Although the therapy continued to show evidence of slowing disease progression, the four-year results failed to meet a key statistical measure and appeared less compelling than earlier three-year data that had been utilized as the basis for a Biologics License Application (BLA). This disappointed investors and raised concerns regarding the treatment 's long-term durability and its prospects for regulatory approval.
If you suffered a loss on your uniQure N.V. securities and would like to explore a potential recovery under the federal securities laws, Learn More About the Investigation or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates.
WHY LEVI & KORSINSKY:Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services ' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212)363-7500
Fax: (212)363-7171
SOURCE:Levi & Korsinsky, LLP
View the original press release on ACCESS Newswire
© 2026 ACCESS Newswire. All Rights Reserved.
